Evidence map›Paper›PMID 36671235›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Rapid Detection of Carbapenemase and Extended-Spectrum β-Lactamase Producing Gram-Negative Bacteria Directly from Positive Blood Cultures Using a Novel Protocol.

Diego Fernando Josa, Ingrid Gisell Bustos, Soad Amira Yusef, Stephanie Crevoisier, Edwin Silva, Natalia López, Rafael Leal, Isabel Torres Molina, Juan Pablo Osorio, Gerson Arias and 3 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Diego Fernando JosaResearch Group Cardiovascular Medicine and Specialties of High Complexity, Fundación Clínica Shaio, Bogotá 110121, Colombia.ORCID 0000-0003-0870-7257
Ingrid Gisell BustosResearch Group Cardiovascular Medicine and Specialties of High Complexity, Fundación Clínica Shaio, Bogotá 110121, Colombia.
Soad Amira YusefDepartment of Critical Medicine, Fundación Clínica Shaio, Bogotá 110111, Colombia.
Stephanie CrevoisierDepartment of Critical Medicine, Fundación Clínica Shaio, Bogotá 110111, Colombia.ORCID 0000-0001-7892-7066
Edwin SilvaResearch Group Cardiovascular Medicine and Specialties of High Complexity, Fundación Clínica Shaio, Bogotá 110121, Colombia.ORCID 0000-0001-8117-0957
Natalia LópezResearch Group Cardiovascular Medicine and Specialties of High Complexity, Fundación Clínica Shaio, Bogotá 110121, Colombia.
Rafael LealResearch Group Cardiovascular Medicine and Specialties of High Complexity, Fundación Clínica Shaio, Bogotá 110121, Colombia.
Isabel Torres MolinaResearch Group Cardiovascular Medicine and Specialties of High Complexity, Fundación Clínica Shaio, Bogotá 110121, Colombia.
Juan Pablo OsorioResearch Group Cardiovascular Medicine and Specialties of High Complexity, Fundación Clínica Shaio, Bogotá 110121, Colombia.
Gerson AriasResearch Group Cardiovascular Medicine and Specialties of High Complexity, Fundación Clínica Shaio, Bogotá 110121, Colombia.
Fabián Cortés-MuñozResearch Group Cardiovascular Medicine and Specialties of High Complexity, Fundación Clínica Shaio, Bogotá 110121, Colombia.
Carolina SánchezResearch Group Cardiovascular Medicine and Specialties of High Complexity, Fundación Clínica Shaio, Bogotá 110121, Colombia.
Luis Felipe ReyesUnisabana Center of Translational Science, Universidad de la Sabana, Chía 53753, Colombia.ORCID 0000-0003-1172-6539
Universidad de La Sabana · CO

Funding

Fundacion Clinica Shaio 001
6 · The paper itself

Abstract

backgroundEarly and adequate antibiotic treatment is the cornerstone of improving clinical outcomes in patients with bloodstream infections (BSI). Delays in appropriate antimicrobial therapy have catastrophic consequences for patients with BSI. Microbiological characterization of multi-drug resistant pathogens (MDRP) allows clinicians to provide appropriate treatments. Current microbiologic techniques may take up to 96 h to identify causative pathogens and their resistant patterns. Therefore, there is an important need to develop rapid diagnostic strategies for MDRP. We tested a modified protocol to detect carbapenemase and extended-spectrum β-lactamase (ESBL) producing Gram-negative bacteria (GNB) from positive blood cultures.

methodsThis is a prospective cohort study of consecutive patients with bacteremia. We developed a modified protocol using the HB&L

resultsNinety-six patients with BSI were included in the study. A total of 161 positive blood cultures were analyzed.

conclusionsHere, we provide novel evidence that using our HB&L

Indexed as

blood culturesbloodstream infectioncarbapenemasesextended-spectrum β-lactamase (ESBL)nephelometryrapid diagnostic test

Identifiers

PMID36671235
PMCPMC9854742
OpenAlexW4313260674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.